Skip to content

13F-HR filed by Eversept Partners, LP

Eversept Partners, LP filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-13, with 59 holding rows worth $320,311,000.

Accession
0001697013-19-000012
Filed
2019-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 59 entries on the cover page, a total value of $320,311,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $320,311,000 with VALUE read as thousands by filing date, 13F file number 028-18369. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR983,085$42,337,000thousands by filing date
ENSIGN GROUP INC29358P101COM586,674$27,849,000thousands by filing date
Danaher Corporation235851102COM178,704$25,839,000thousands by filing date
ZOGENIX INC.98978L204Common Stock643,818$25,778,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR236,392$22,769,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW1,329,695$20,158,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR240,000$11,119,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW344,698$8,876,000thousands by filing date
ENVISTA HOLDINGS CORPORATION29415F104COM318,000$8,866,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM50,909$8,625,000thousands by filing date
ILLUMINA INC452327109COM26,750$8,138,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock92,040$7,402,000thousands by filing date
AUDENTES THERAPEUTICS INC.05070R104Common Stock253,726$7,127,000thousands by filing date
DEXCOM INC COM252131107Stock44,550$6,649,000thousands by filing date
R1 RCM INC749397105COM725,972$6,483,000thousands by filing date
ABIOMED INC003654100COM29,950$5,328,000thousands by filing date
OMEGA HEALTHCARE INVS INC COM681936100REIT106,500$4,451,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock773,501$4,343,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS256,000$4,257,000thousands by filing date
TELIGENT INC NEW87960W104COM4,424,222$4,202,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR36,004$4,103,000thousands by filing date
LTC PPTYS INC COM502175102REIT69,327$3,551,000thousands by filing date
SABRA HEALTH CARE REIT INC COM78573L106REIT154,100$3,538,000thousands by filing date
MODEL N INC607525102COM120,695$3,350,000thousands by filing date
CARETRUST REIT INC COM14174T107REIT137,464$3,260,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM708,020$2,981,000thousands by filing date
ARQULE INC04269E107COM412,388$2,957,000thousands by filing date
HESKA CORP42805E306COM40,824$2,893,000thousands by filing date
EHEALTH INC28238P109COM42,653$2,849,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK607,383$2,187,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM140,656$2,184,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW181,700$2,068,000thousands by filing date
TRICIDA INC89610F101COM65,568$2,024,000thousands by filing date
MACROGENICS INC556099109COM154,824$1,976,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock215,609$1,943,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM79,509$1,915,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock654,460$1,875,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM160,295$1,840,000thousands by filing date
SCPHARMACEUTICALS INC810648105COM221,636$1,301,000thousands by filing date
AMARIN CORPORATION PLC -ADR023111906ADR1,611$1,096,000thousands by filing date
AGILE THERAPEUTICS INC00847L100COM909,485$1,078,000thousands by filing date
INVACARE CORP461203101COMMON STOCK129,361$970,000thousands by filing date
AFFIMED N VN01045108COM322,171$947,000thousands by filing date
OTONOMY INC68906L105COM376,342$899,000thousands by filing date
CODEXIS INC192005106COM63,000$864,000thousands by filing date
SAVARA INC805111101COM316,679$839,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM22,000$747,000thousands by filing date
OPTINOSE INC68404V100COM105,106$736,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM69,708$715,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM41,074$590,000thousands by filing date
NEWLINK GENETICS CORP651511107COM272,983$434,000thousands by filing date
PFENEX INC717071104COM47,968$405,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK18,029$361,000thousands by filing date
AKORN INC009728106COM40,242$153,000thousands by filing date
HEALTHEQUITY INC COM42226A107Stock640$37,000thousands by filing date
AIMMUNE THERAPEUTICS INC00900T907CALL91$21,000thousands by filing date
AIMMUNE THERAPEUTICS INC00900T957PUT100$15,000thousands by filing date
CEL SCI CORP150837957PUT428$10,000thousands by filing date
CELGENE CORP151020112RIGHT 12/31/20306,000$3,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001697013-19-000012this filing2019-11-13acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000013 base2023-11-08acceptance time not in the bulk data set